SKBA Capital Management’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.8M Sell
1,015,350
-139,100
-12% -$1.52M 1.78% 28
2026
Q1
$13.4M Buy
1,154,450
+3,710
+0.3% +$46.3K 1.84% 22
2025
Q4
$13.2M Buy
1,150,740
+10,310
+0.9% +$121K 1.87% 25
2025
Q3
$14.5M Buy
1,140,430
+142,900
+14% +$2.07M 2% 15
2025
Q2
$15.8M Buy
997,530
+340,940
+52% +$5.1M 2.28% 12
2025
Q1
$9.81M Buy
656,590
+125,000
+24% +$2.21M 1.46% 34
2024
Q4
$10.1M Buy
+531,590
New +$11.2M 1.59% 25

Other funds holding XRAY

SKBA Capital Management's XRAY Position: Q2 2026 in Review

SKBA Capital Management reduced its Dentsply Sirona (XRAY) stake by 12% in Q2 2026, selling an estimated $1.52M and leaving 1,015,350 shares worth $10.8M. The position accounts for 1.78% of the portfolio, ranked #28.

SKBA Capital Management first reported a position in XRAY in Q4 2024 and has held it in 7 quarters since. The position peaked at $15.8M in Q2 2025. 373 funds tracked by Wall St. Rank hold XRAY as of Q2 2026.

  • SKBA Capital Management held 1,015,350 shares of Dentsply Sirona worth $10.8M as of Q2 2026.
  • SKBA Capital Management sold 139,100 Dentsply Sirona shares in Q2 2026, an estimated $1.52M.
  • Dentsply Sirona made up 1.78% of SKBA Capital Management's portfolio in Q2 2026, its #28 holding.
  • SKBA Capital Management first reported a position in Dentsply Sirona in Q4 2024 and has held it in 7 quarters since.
  • SKBA Capital Management's Dentsply Sirona position peaked at $15.8M in Q2 2025.
  • 373 funds tracked by Wall St. Rank held Dentsply Sirona as of Q2 2026.

Based on SKBA Capital Management's 13F filing for Q2 2026, filed 11 Aug 2026.